AUNA
HoldUnloved QualityAI screen passAuna SA · Healthcare · Luxembourg · $381M cap · $769K/day traded
$5.03 -7.0% · close 22 Oct · scored 23 Oct
StockRank down 3.7 since 22 Oct: Momentum down 4 after a 7% price fall.
Unloved Quality: Strong and cheap; the market has not turned yet.
Report expected 19 Nov: the next-year EPS estimate has fallen 2.1% over the last 13 weeks.
As of 23 Oct 2026, MoatMap's StockRank for Auna SA (AUNA) is 57/100, ranked against 24,000+ stocks in 35 markets (Quality 51, Value 51, Momentum 48, each scored against its sector).
Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →
Auna clears stage one on net insider buying (0.28% bought against 0.06% sold) with all three legs above the floor and V81 leading. A Latin American hospital and oncology network at a deep discount with management adding is the configuration the calibrated bar is designed to surface, and nothing adverse is on file.
The ranks quoted here are from the day it was written; today's Quality, Value and Momentum are the bars above.
ABOUT AUNA SA
Read
Auna SA is a leading healthcare provider in Spanish-speaking Latin America, operating a network of hospitals, clinics, and oncological centers, alongside offering healthcare plans. The company's competitive moat is its vertically integrated healthcare model, which aligns insurance and delivery to optimize costs and patient outcomes. It operates as a dominant medical care facilities player in Peru, Colombia, and Mexico.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 714.3M | 1.1B | 1.3B | 1.3B | 21.4% | 1.4B | 1.4B | 1.5B | 8.0% |
| EPS | -0.83 | -2.45 | 1.17 | 0.94 | -19.0% | — | 0.64 | 0.81 | -7.6% |
| Shares | 30.1M | 30.1M | 30.1M | 30.1M | 0.0% | 30.1M | — | — | — |
| Debt | 1.0B | 1.1B | 1.1B | 1.1B | 1.4% | 1.1B | — | — | — |
| Equity | 310.3M | 426.9M | 430.4M | 466.4M | 14.5% | — | — | — | — |
| Op CF | 47.4M | 169.7M | 194.8M | 193.0M | 59.7% | 248.2M | — | — | — |
| Inv CF | -935.1M | -50.4M | -69.0M | -23.4M | — | — | — | — | — |
| Fin CF | 912.1M | -107.8M | -121.8M | -141.9M | — | — | — | — | — |
23% above its 52-week low and back above a rising 50-day average since 16 Oct 2026.
The Momentum score still reads 48: it weighs six months of price and earnings revisions, so it trails a turn like this.
Swung more than 54% of stocks we rank over the past year (44% a year).
How this is worked out
StockRank judges the business. The price check reads only the chart: it is the price side of the Momentum score, in words.
The rules: Still falling is a new 52-week low in the last two weeks, at least 25% below the high. Finding a floor is no new low since. Turning up is 20 or more trading days without a new low, at least 10% off it, and back above a rising 50-day average. In an uptrend is above the 200-day average and within 15% of the high.
In 2,112 US drawdowns since 2001, buying while the price was still falling was followed by a further 20% drop 42% of the time. Waiting for a turn like this one cut that to 33%, at about 7% higher prices and with no better returns. Part of that cut is simply not buying: 13% of falls never turned, and waiting kept those out. Among turns that were bought, 38% still fell another 20%, and 33% of turns were followed by a new low within six months. The benefit was largest in crashes such as 2008 and 2020.
What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of AUNA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| AUNA | Auna SA(you) | $381M | 57 | Hold |
| ALVO-SDB.ST | Alvotech | $2.0B | 34 | Sell |
| ERF.PA | Eurofins Scientific SE | $14.8B | 80 | Strong Buy |
Peer medians: ROE 11.3% · P/E 27.2x · Gross margin 60.7%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.